Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Intangibles: 2021-2025

Historic Intangibles for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $15.5 million.

  • Kiniksa Pharmaceuticals International's Intangibles fell 6.06% to $15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year decrease of 6.06%. This contributed to the annual value of $16.2 million for FY2024, which is 18.75% down from last year.
  • Kiniksa Pharmaceuticals International's Intangibles amounted to $15.5 million in Q3 2025, which was down 1.59% from $15.8 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Intangibles registered a high of $20.0 million during Q1 2021, and its lowest value of $15.5 million during Q3 2025.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Intangibles had a median value of $16.8 million in 2024 and averaged $17.4 million.
  • Data for Kiniksa Pharmaceuticals International's Intangibles shows a maximum YoY fell of 18.75% (in 2024) over the last 5 years.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Intangibles (Quarterly) stood at $20.0 million in 2021, then remained steady at $20.0 million in 2022, then remained steady at $20.0 million in 2023, then fell by 18.75% to $16.2 million in 2024, then fell by 6.06% to $15.5 million in 2025.
  • Its Intangibles was $15.5 million in Q3 2025, compared to $15.8 million in Q2 2025 and $16.0 million in Q1 2025.